The Week Ahead: Data on Home Prices and the FDA’s Decision on a Cholesterol-Lowering Drug
This week, the Food and Drug Administration is expected to approve Repatha; several important pieces of housing market data will be released; and shareholders in Mylan are scheduled to vote on a matter related to a takeover bid.
